Cited by — Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer.
No admitted local citation edges point to this work yet.